The Health Services sector continued to exhibit strong signs of deal activity during 2017 and has now eclipsed 200+ transactions for 13 consecutive quarters. We expect a continuation in this Health Services deal activity in 2018 based on a variety of trends and factors highlighted in the report.
In a year of regulatory uncertainty, 2017 was an active year for US Health Services deals. Although deal volume decreased slightly year-over-year, deal value increased significantly. There were five megadeals altogether, including two private equity transactions in the CRO space.
In 2017, the number of deals decreased by 2.5% to 967, but deal value increased 145.8% to $175.2 billion. Deal volume was greatest in Q1 (270 deals), and deal value was greatest in Q4 ($99.2 billion).